Rat pulmonary responses to inhaled nano-TiO2: Effect of primary particle size and agglomeration state

Particle and Fibre Toxicology

Volumn 10, Issue 1, 2013, Pages

  Noël, Alexandra ^a   Charbonneau, Michel ^b   Cloutier, Yves ^c   Tardif, Robert ^a   Truchon, Ginette ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT DE RECHERCHE ROBERT SAUVÉ EN SANTÉ ET EN SÉCURITÉ DU TRAVAIL   (Canada)

Author keywords

Agglomeration state; Cytotoxicity; Inflammation; Inhalation; Oxidative stress; Primary particle size; TiO2 nanoparticles

Indexed keywords

8 ISOPROSTANE; LACTATE DEHYDROGENASE; METAL NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; ENZYME ACTIVITY; LUNG LAVAGE; LUNG TOXICITY; MALE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PNEUMONIA; PRIORITY JOURNAL; RAT;

RATTUS;

AEROSOLS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENDOCYTOSIS; INHALATION EXPOSURE; LEUKOCYTES; LUNG; MACROPHAGES; MALE; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; RATS; RATS, INBRED F344; SURFACE PROPERTIES; TISSUE DISTRIBUTION; TITANIUM;

EID: 84896703870     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-10-48     Document Type: Article

References (99)

1. Lux Research The Nanotech Report 2004, http://www.luxresearchinc.com/ 2004, Lux Research.
2. McIntyre RA. Common nano-materials and their use in real world applications. Sci Progress 2012, 95:1-22.
3. Donaldson K, Seaton A. A short history of the toxicology of inhaled particles. Part Fibre Toxicol 2012, 9:13. 10.1186/1743-8977-9-13, 3436721, 22559156.
4. Oberdorster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect 1992, 97:193-199. 1519541, 1396458.
5. Oberdorster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 1994, 102(Suppl 5):173-179.
6. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175:191-199. 10.1006/taap.2001.9240, 11559017.
7. Renwick LC, Brown D, Clouter A, Donaldson K. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup Environ Med 2004, 61:442-447. 10.1136/oem.2003.008227, 1740792, 15090666.
8. Duffin R, Mills NL, Donaldson K. Nanoparticles-a thoracic toxicology perspective. Yonsei Med J 2007, 48:561-572. 10.3349/ymj.2007.48.4.561, 2628054, 17722227.
9. Grassian VH, Adamcakova-Dodd A, Pettibone JM, O'Shaughnessy PT, Thorne PS. Inflammatory response of mice to manufactured titanium dioxide nanoparticles: comparison of size effects through different exposure routes. Nanotoxicol 2007, 1:211-226.
10. Kobayashi N, Naya M, Endoh S, Maru J, Yamamoto K, Nakanishi J. Comparative pulmonary toxicity study of nano-TiO(2) particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results. Toxicology 2009, 264(1-2):110-118.
11. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 2009, 109:152-167. 10.1093/toxsci/kfp046, 19251949.
12. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005, 2:8. 10.1186/1743-8977-2-8, 1260029, 16209704.
13. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627. 10.1126/science.1114397, 16456071.
14. Auffan M, Rose J, Bottero JY, Lowry GV, Jolivet JP, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 2009, 4:634-641. 10.1038/nnano.2009.242, 19809453.
15. Liang G, Pu Y, Yin L, Liu R, Ye B, Su Y, Li Y. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A 2009, 72:740-745. 10.1080/15287390902841516, 19492237.
16. Liu W, Wu Y, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 2010, 4:319-330. 10.3109/17435390.2010.483745, 20795913.
17. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839. 10.1289/ehp.7339, 1257642, 16002369.
18. Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K. Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip Rev Nanomed.Nanobiotechnol 2012, 4:399-413.
19. Grassian VH, O'shaughnessy PT, Mcakova-Dodd A, Pettibone JM, Thorne PS. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Health Perspect 2007, 115:397-402. 10.1289/ehp.10302R, 1849915, 17431489.
20. United-States Environmental Protection Agency (EPA) Nanomaterial Research Strategy 2009, Washington, D.C: Office of Research and Development U.S. Environmental Protection Agency, Report no EPA620/K-09/011, United-States Environmental Protection Agency (EPA).
21. Organization for Economic Co-operation and Development (OECD) List of manufactured nanomaterials and list of endpoints for phase one of the sponsorship programme for the testing of manufactured nanomaterials: revision. Environment, Health and Safety Publications Series on the Safety of Manufactured Nanomaterials Series on the Safety of Manufactured Nanomaterials No. 27 ENV/JM/MONO(2010)46 http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono(2010)46&doclanguage=en, Organization for Economic Co-operation and Development (OECD).
22. Boutou-Kempf O, Marchand JL, Radauceanu A, Witschger O, Imbernon E. Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace. J Occup Environ Med 2011, 53(6 Suppl):S103-S107.
23. National Institute for Occupational Safety and Health (NIOSH) Occupational Exposure to Titanium Dioxide 2011, Department of Health and Human Services, Centers for Disease Control and Prevention: DHHS, Publication No. 2011-160. Current intelligence bulletin 63. http://www.cdc.gov/niosh/docs/2011-160/pdfs/2011-160.pdf, National Institute for Occupational Safety and Health (NIOSH).
24. Fryzek JP, Chadda B, Marano D, White K, Schweitzer S, McLaughlin JK, Blot WJ. A cohort mortality study among titanium dioxide manufacturing workers in the United States. J Occup Environ Med 2003, 45:400-409. 10.1097/01.jom.0000058338.05741.45, 12708144.
25. Hext PM, Tomenson JA, Thompson P. Titanium dioxide: inhalation toxicology and epidemiology. Ann Occup Hyg 2005, 49:461-472. 10.1093/annhyg/mei012, 15790613.
26. Hsu LY, Chein HM. Evaluation of nanoparticle emission for TiO2 nanopowder coating materials. J Nanopart Res 2007, 9:157-163.
27. Demou E, Stark WJ, Hellweg S. Particle emission and exposure during nanoparticle synthesis in research laboratories. Ann Occup Hyg 2009, 53:829-838. 10.1093/annhyg/mep061, 19703918.
28. Curwin B, Bertke S. Exposure characterization of metal oxide nanoparticles in the workplace. J Occup Environ Hyg 2011, 8:580-587. 10.1080/15459624.2011.613348, 21936697.
29. Lee JH, Kwon M, Ji JH, Kang CS, Ahn KH, Han JH, Yu IJ. Exposure assessment of workplaces manufacturing nanosized TiO2 and silver. Inhal Toxicol 2011, 23:226-236. 10.3109/08958378.2011.562567, 21456955.
30. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004, 77:347-357. 10.1093/toxsci/kfh019, 14600271.
31. Ma-Hock L, Gamer AO, Landsiedel R, Leibold E, Frechen T, Sens B, Linsenbuehler M, van Ravenzwaay B. Generation and characterization of test atmospheres with nanomaterials. Inhal Toxicol 2007, 19:833-848. 10.1080/08958370701479190, 17687715.
32. Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, Van Ravenzwaay B, Landsiedel R. Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal Toxicol 2009, 21:102-118. 10.1080/08958370802361057, 18800274.
33. Noël A, Cloutier Y, Wilkinson KJ, Dion C, Halle S, Maghni K, Tardif R, Truchon G. Generating Nano-Aerosols from TiO(2) (5 nm) Nanoparticles Showing Different Agglomeration States. Application to Toxicological Studies. J Occup Environ Hyg 2013, 10:86-96. 10.1080/15459624.2012.748340, 23252512.
34. Noël A, L'Esperance G, Cloutier Y, Plamondon P, Boucher J, Philippe S, Dion C, Truchon G, Zayed J. Assessment of the contribution of electron microscopy to nanoparticle characterization sampled with two cascade impactors. J Occup Environ Hyg 2013, 10:155-172. 10.1080/15459624.2012.760391, 23356435.
35. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett 2007, 171:99-110. 10.1016/j.toxlet.2007.04.008, 17566673.
36. Zook JM, Maccuspie RI, Locascio LE, Halter MD, Elliott JT. Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 2011, 5:517-530. 10.3109/17435390.2010.536615, 21142841.
37. Kreyling WG, Semmler-Behnke M, Takenaka S, Moller W. Differences in the Biokinetics of Inhaled Nano- versus Micrometer-Sized Particles. Acc Chem Res 2013, 46:714-722. 10.1021/ar300043r, 22980029.
38. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology 2007, 230:90-104. 10.1016/j.tox.2006.11.002, 17196727.
39. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci 2006, 91:227-236. 10.1093/toxsci/kfj140, 16495353.
40. Jiang J, Oberdorster G, Elder A, Gelein R, Mercer P, Biswas P. Does Nanoparticle Activity Depend upon Size and Crystal Phase?. Nanotoxicology 2008, 2:33-42. 10.1080/17435390701882478, 2935086, 20827377.
41. Noël A, Maghni K, Cloutier Y, Dion C, Wilkinson KJ, Halle S, Tardif R, Truchon G. Effects of inhaled nano-TiO2 aerosols showing two distinct agglomeration states on rat lungs. Toxicol Lett 2012, 214:109-119. 10.1016/j.toxlet.2012.08.019, 22944471.
42. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. Ultrafine particles. Occup Environ Med 2001, 58:211-216. 199, 10.1136/oem.58.3.211, 1740105, 11171936.
43. Scherbart AM, Langer J, Bushmelev A, van Berlo D, Haberzettl P, van Schooten FJ, Schmidt AM, Rose CR, Schins RP, Albrecht C. Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part Fibre Toxicol 2011, 8:31. 10.1186/1743-8977-8-31, 3214143, 21995556.
44. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6:1794-1807. 10.1021/nl061025k, 16895376.
45. Ferin J, Oberdorster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol 1992, 6:535-542. 10.1165/ajrcmb/6.5.535, 1581076.
46. Oberdörster G, Cox C, Gelein R. Intratracheal instillation versus intratracheal-inhalation of tracer particles for measuring lung clearance function. Exp Lung Res 1997, 23:17-34. 10.3109/01902149709046045, 9028797.
47. Balasubramanian SK, Poh KW, Ong CN, Kreyling WG, Ong WY, Yu LE. The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials 2013, 34:5439-5452. 10.1016/j.biomaterials.2013.03.080, 23639527.
48. Hervé-Bazin B. Les nanoparticules un enjeu majeur pour la santé au travail? 2007, 701. France: EDP Sciences.
49. Sager TM, Kommineni C, Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol 2008, 5:17. 10.1186/1743-8977-5-17, 2633346, 19046442.
50. Muhlfeld C, Mayhew TM, Gehr P, Rothen-Rutishauser B. A novel quantitative method for analyzing the distributions of nanoparticles between different tissue and intracellular compartments. J Aerosol Med 2007, 20:395-407. 10.1089/jam.2007.0624, 18158712.
51. Muhlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol 2007, 4:11. 10.1186/1743-8977-4-11, 2211502, 17996124.
52. Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 2008, 294:L817-L829. 10.1152/ajplung.00442.2007, 18263666.
53. Seipenbusch M, Binder A, Kasper G. Temporal evolution of nanoparticle aerosols in workplace exposure. Ann Occup Hyg 2008, 52:707-716. 10.1093/annhyg/men067, 18927101.
54. Kanapilly GM, Wolff RK, DeNee PB, McClellan RO. Generation, characterization and inhalation deposition of ultrafine aggregate aerosols. Ann Occup Hyg 1982, 26:77-91. 10.1093/annhyg/26.1.77, 7181306.
55. Pratten MK, Lloyd JB. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys Acta 1986, 881:307-313. 10.1016/0304-4165(86)90020-6, 3008849.
56. Oberdörster G. Lung clearance of inhaled insoluble and soluble particles. J Aerosol Med 1988, 1:289-329.
57. Yang W, Peters JI, Williams RO. Inhaled nanoparticles-a current review. Int J Pharm 2008, 356:239-247. 10.1016/j.ijpharm.2008.02.011, 18358652.
58. Cho WS, Duffin R, Poland CA, Howie SE, MacNee W, Bradley M, Megson IL, Donaldson K. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 2010, 118:1699-1706. 10.1289/ehp.1002201, 3002189, 20729176.
59. Warheit DB, Reed KL, Delorme MP. Embracing a weight-of-evidence approach for establishing NOAELs for nanoparticle inhalation toxicity studies. Toxicol Pathol 2012, .
60. Preining E. The physical nature of very, very small particles and its impact on their behaviour. J Aerosol Sci 1998, 29:481-495.
61. Bermudez E, Mangum JB, Asgharian B, Wong BA, Reverdy EE, Janszen DB, Hext PM, Warheit DB, Everitt JI. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. Toxicol Sci 2002, 70:86-97. 10.1093/toxsci/70.1.86, 12388838.
62. Geiser M, Kreyling WG. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 2010, 7:2. 10.1186/1743-8977-7-2, 2826283, 20205860.
63. Cavaillon JM. Les cytokines 1993, 412. Paris: Masson, 2-225-84174-8.
64. Nicola NA. Guidebook to cytokines and their receptors. A Sambrook and Tooze publication 1994, 261. Oxford University Press, 0-19-859946-3.
65. Goldsby RA, Kindt TJ, Osborne BA. Immunologie le cours de Janis Kuby 2000, 660. New-York and Basingstoke: W.H. Freeman and Company.
66. Oberdorster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder AC. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 2000, 96:5-74.
67. Tetley TD. Health effects of nanomaterials. Biochem Soc Trans 2007, 35:527-531.
68. Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, Takenaka S, Stettmaier K, Bors W, Ghio A, Samet JM, Heyder J. Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic Biol Med 2005, 38:1080-1092. 10.1016/j.freeradbiomed.2005.01.004, 15780766.
69. Fahmy B, Cormier SA. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol In Vitro 2009, 23:1365-1371. 10.1016/j.tiv.2009.08.005, 2756312, 19699289.
70. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. Identification of the mechanisms that drive the toxicity of TiO(2) particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol 2009, 6:33. 10.1186/1743-8977-6-33, 2804608, 20017923.
71. Rossi EM, Pylkkanen L, Koivisto AJ, Vippola M, Jensen KA, Miettinen M, Sirola K, Nykasenoja H, Karisola P, Stjernvall T, Vanhala E, Kiilunen M, Pasanen P, Makinen M, Hameri K, Joutsensaari J, Tuomi T, Jokiniemi J, Wolff H, Savolainen K, Matikainen S, Alenius H. Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice. Toxicol Sci 2010, 113:422-433. 10.1093/toxsci/kfp254, 19875681.
72. Halappanavar S, Jackson P, Williams A, Jensen KA, Hougaard KS, Vogel U, Yauk CL, Wallin H. Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study. Environ Mol Mutagen 2011, 52:425-439. 10.1002/em.20639, 3210826, 21259345.
73. Van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. Comparing fate and effects of three particles of different surface properties: nano-TiO(2), pigmentary TiO(2) and quartz. Toxicol Lett 2009, 186:152-159. 10.1016/j.toxlet.2008.11.020, 19114093.
74. Lindberg HK, Falck GC, Catalan J, Koivisto AJ, Suhonen S, Jarventaus H, Rossi EM, Nykasenoja H, Peltonen Y, Moreno C, Alenius H, Tuomi T, Savolainen KM, Norppa H. Genotoxicity of inhaled nanosized TiO(2) in mice. Mutat Res 2012, 745:58-64. 10.1016/j.mrgentox.2011.10.011, 22094288.
75. McKinney W, Jackson M, Sager TM, Reynolds JS, Chen BT, Afshari A, Krajnak K, Waugh S, Johnson C, Mercer RR, Frazer DG, Thomas TA, Castranova V. Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles. Inhal Toxicol 2012, 24:447-457. 10.3109/08958378.2012.685111, 22642294.
76. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001, 109(Suppl 4):547-551.
77. Takenaka S, Karg E, Kreyling WG, Lentner B, Moller W, Behnke-Semmler M, Jennen L, Walch A, Michalke B, Schramel P, Heyder J, Schulz H. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006, 18:733-740. 10.1080/08958370600748281, 16774862.
78. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 2002, 65:1531-1543. 10.1080/00984100290071658, 12396867.
79. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445. 10.1080/08958370490439597, 15204759.
80. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im HV, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005, 113:1555-1560. 10.1289/ehp.8006, 1310918, 16263511.
81. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 2008, 38:371-376. 10.1165/rcmb.2007-0138OC, 17947511.
82. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114:1172-1178. 10.1289/ehp.9030, 1552007, 16882521.
83. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, Oberdorster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 2009, 21(Suppl 1):55-60.
84. Chen Z, Meng H, Xing G, Chen C, Zhao Y, Jia G, Wang T, Yuan H, Ye C, Zhao F, Chai Z, Zhu C, Fang X, Ma B, Wan L. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 2006, 163:109-120. 10.1016/j.toxlet.2005.10.003, 16289865.
85. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 2010, 28:1300-1303. 10.1038/nbt.1696, 3058321, 21057497.
86. Diang HM, Tian WD, Ma YQ. Designing nanoparticle translocation through membranes by computer simulations. ACS Nano 2012, 6:1230-1238. 10.1021/nn2038862, 22208867.
87. Zaqout MS, Sumizawa T, Igisu H, Wilson D, Myojo T, Ueno S. Binding of titanium dioxide nanoparticles to lactate dehydrogenase. Environ Health Prev Med 2012, 17:341-345. 10.1007/s12199-011-0245-7, 3390560, 21993949.
88. Meena R, Pal R, Pradhan SN, Rani M, Paulraj R. Comparative study of TiO2 and TiSiO4 nanoparticles induced oxidative stress and apoptosis of HEK-293 cells. Adv Mat Lett 2012, 3:459-465.
89. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 2006, 92:174-185. 10.1093/toxsci/kfj197, 16613837.
90. Schanen BC, Karakoti AS, Seal S, Drake DR, Warren WL, Self WT. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano 2009, 3:2523-2532. 10.1021/nn900403h, 3038685, 19769402.
91. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010, 267:89-105. 10.1111/j.1365-2796.2009.02187.x, 20059646.
92. Braydich-Stolle LK, Schaeublin NM, Murdock RC, Jiang J, Biswas P, Schlager JJ, Hussain SM. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J Nanopart Res 2009, 11:1361-1374.
93. Zhang HZ, Penn RL, Hamers RJ, Banfield JF. Enhanced adsorption of molecules on surfaces of nanocrystalline particles. J Phys Chem B 1999, 103:4656-4662.
94. Brouwer DH, Gijsbers JH, Lurvink MW. Personal exposure to ultrafine particles in the workplace: exploring sampling techniques and strategies. Ann Occup Hyg 2004, 48:439-453. 10.1093/annhyg/meh040, 15240340.
95. Peters TM, Elzey S, Johnson R, Park H, Grassian VH, Maher T, O'Shaughnessy P. Airborne monitoring to distinguish engineered nanomaterials from incidental particles for environmental health and safety. J Occup Environ Hyg 2009, 6:73-81. 10.1080/15459620903249695, 19034793.
96. Bérubé K, Balharry D, Sexton K, Koshy L, Jones T. Combustion-derived nanoparticles: mechanisms of pulmonary toxicity. Clin Exp Pharmacol Physiol 2007, 34:1044-1050. 10.1111/j.1440-1681.2007.04733.x, 17714092.
97. Scarino A, Tardif R, Charbonneau M. Influence of ALDH2 polymorphism on ethanol kinetics and pulmonary effects in male and female rats exposed to ethanol vapors. Inhal Toxicol 2009, 21:193-199. 10.1080/08958370802372815, 18925476.
98. Ratthe C, Ennaciri J, Garces Goncalves DM, Chiasson S, Girard D. Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism. Mediators Inflamm 2009, 2009:193970. 2742652, 19753321.
99. Goncalves DM, Girard D. Titanium dioxide (TiO2) nanoparticles induce neutrophil influx and local production of several pro-inflammatory mediators in vivo. Int Immunopharmacol 2011, 11:1109-1115. 10.1016/j.intimp.2011.03.007, 21426949.